Is anemia a new cardiovascular risk factor?

International Journal of Cardiology

Volumn 186, Issue , 2015, Pages 117-124

  Kaiafa, Georgia ^a   Kanellos, Ilias ^a   Savopoulos, Christos ^a   Kakaletsis, Nikolaos ^a   Giannakoulas, George ^a   Hatzitolios, Apostolos I ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Acute coronary syndromes (ACS); Acute myocardial infarction (AMI); Anemia; Chronic heart failure (CHF); Heart failure (HF)

Indexed keywords

ADIPONECTIN; AMLODIPINE; ANTIANEMIC AGENT; C REACTIVE PROTEIN; CANDESARTAN; CARVEDILOL; ERYTHROPOIETIN; ETANERCEPT; FERRIC CARBOXYMALTOSE; HEMOGLOBIN; IRON; METOPROLOL; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; VALSARTAN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IRON DEFICIENCY; IRON THERAPY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CARDIOVASCULAR DISEASES; COMPLICATION;

ANEMIA; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS;

EID: 84929156479     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.159     Document Type: Review

References (77)

1. D.T. Mangano Perioperative cardiac morbidity Anesthesiology 72 1 1990 153 184
2. R.K. Spence The economic burden of anemia in heart failure Heart Fail. Clin. 6 3 2010 373 383
3. World Health Organization Nutritional anemias: report of a WHO scientific group WHO Tech Rep Ser 405 1968 5 37
4. Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, O. Wiklund, and ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur. Heart J. 32 14 2011 1769 1818
5. N. Meneveau, F. Schiele, M.F. Seronde, V. Descotes-Genon, J. Oettinger, and R. Chopard Reseau de Cardiologie de Franche Comte Anaemia for risk assessment of patients with acute coronary syndromes Am. J. Cardiol. 103 4 2009 442 447
6. F. Bellotto, and A. Cati Anemia and myocardial ischemia: relationships and interferences Recenti Prog. Med. 97 3 2006 153 164
7. K. Hara, T. Uchida, K. Takebayashi, Y. Sakai, T. Inoue, and T. Inukai Determinants of serum high molecular weight (HMW) adiponectin levels in patients with coronary artery disease: associations with cardio-renal-anemia syndrome Intern. Med. 50 24 2011 2953 2960
8. A. Solomon, A. Blum, A. Peleg, E.I. Lev, D. Leshem-Lev, and Y. Hasin Endotheliac progenitor cells are suppressed in anemic patients with acute coronary syndrome Am. J. Med. 125 6 2012 604 611
9. M. Rousseau, R.T. Yan, M. Tan, C.J. Lefkowitz, A. Casanova, and D. Fitchett Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring Am. J. Cardiol. 106 10 2010 1417 1422
10. Y.J. Hong, M.H. Jeong, Y.H. Choi, J.A. Song, D.H. Kim, and K.H. Lee Relation between anemia and vulnerable coronary plaque components in patients with acute coronary syndrome: virtual histology-intravascular ultrasound analysis J. Korean Med. Sci. 27 4 2012 370 376
11. Y. Shacham, E. Leshem-Rubinow, E. Ben-Assa, A. Roth, and A. Steinvil Lower admission hemoglobin levels are associated with longer symptom duration in acute ST-elevation myocardial infarction Clin. Cardiol. 37 2 2014 73 77
12. S. Devaraj, D.Y. Xu, and I. Jialal C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis Circulation 107 3 2003 398 404
13. A.C. Salisbury, M. Kosiborod, A.P. Amin, K.J. Reid, K.P. Alexander, and J.A. Spertus Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes Am. J. Cardiol. 108 7 2011 949 954
14. A.C. Salisbury, K.J. Reid, A.P. Amin, J.A. Spertus, and M. Kosiborod Variation in the incidence of hospital-acquired anemia during hospitalization with acute myocardial infarction (data from 57 US hospitals) Am. J. Cardiol. 113 7 2014 1130 1136
15. A.C. Salisbury, K.P. Alexander, K.J. Reid, F.A. Masoudi, S.S. Rathore, and T.Y. Wang Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction Circ. Cardiovasc. Qual. Outcomes 3 4 2010 337 346
16. S.K. James, J. Oldgren, J. Lindbäck, N. Johnston, A. Siegbahn, and L. Wallentin An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease Am. Heart J. 149 4 2005 619 626
17. I. Theurl, E. Aigner, M. Theurl, M. Nairz, M. Seifert, and A. Schroll Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications Blood 113 21 2009 5277 5286
18. R.S. McKechnie, D. Smith, C. Montoye, E. Kline-Rogers, M.J. O'Donnell, and A.C. DeFranco Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention Circulation 110 3 2004 271 277
19. K.S. Rathod, D.A. Jones, V.S. Rathod, D. Bromage, O. Guttmann, and S.M. Gallagher Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI Coron. Artery Dis. 25 1 2014 52 59
20. E. Nikolsky, E.D. Aymong, A. Halkin, C.L. Grines, D.A. Cox, and E. Garcia Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial J. Am. Coll. Cardiol. 44 3 2004 547 553
21. C.H. Huang, C.C. Chang, C.L. Kuo, C.S. Huang, T.W. Chiu, and C.S. Lin Serum iron concentration, but not hemoglobin, correlates with TIMI risk score and 6-month left ventricular performance after primary angioplasty for acute myocardial infarction PLoS One 9 8 2014 e104495
22. V. Kunadian, R. Mehran, A.M. Lincoff, F. Feit, S.V. Manoukian, and M. Hamon Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy trial) Am. J. Cardiol. 114 12 2014 1823 1829
23. M.S. Sabatine, D.A. Morrow, R.P. Giugliano, P.B. Burton, S.A. Murphy, and C.H. McCabe Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 16 2005 2042 2049
24. P. Van der Meer, A.A. Voors, E. Lipsic, W.H. van Gilst, and D.J. van Veldhuisen Erythropoietin in cardiovascular disease Eur. Heart J. 25 4 2004 285 291
25. R.D. Langston, R. Presley, W.D. Flanders, and W.M. McClellan Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction Kidney Int. 64 2003 1398 1405
26. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., and M.H. Drazner 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 128 16 2013 e240 e327
27. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, and K. Dickstein ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 Eur. J. Heart Fail. 14 8 2012 803 869
28. A.P. Maggioni, C. Opasich, I. Anand, S. Barlera, E. Carbonieri, and L. Gonzini Anemia in patients with heart failure: prevalence and prognostic role in a controlled trail and in clinical practice J. Card. Fail. 11 2 2005 91 98
29. A. Ishani, E. Weinhandl, Z. Zhao, D.T. Gilbertson, A.J. Collins, and S. Yusuf Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction J. Am. Coll. Cardiol. 45 3 2005 391 399
30. S. de Denus, J.C. Tardif, M. White, M.G. Bourassa, N. Racine, and S. Levesque Temporal variations in hematocrit values in patients with left ventricular dysfunction: relationship with cause-specific mortality and morbidity and optimal monitoring - further insights from SOLVD Can. J. Cardiol. 24 1 2008 45 48
31. I.S. Anand, M.A. Kuskowski, T.S. Rector, V.G. Florea, R.D. Glazer, and A. Hester Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT Circulation 112 8 2005 1121 1127
32. M. Komajda, S.D. Anker, A. Charlesworth, D. Okonko, M. Metra, and A. Di Lenarda The impact of new onset anemia on morbidity and mortality in chronic heart failure: results from COMET Eur. Heart J. 27 12 2006 1440 1446
33. R. Sharma, D.P. Francis, B. Pitt, P.A. Poole-Wilson, A.J. Coats, and S.D. Anker Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial Eur. Heart J. 25 12 2004 1021 1028
34. I. Anand, J.J. McMurray, J. Whitmore, M. Warren, A. Pham, and M.A. McCamish Anemia and its relationship to clinical outcome in heart failure Circulation 110 2 2004 149 154
35. E. O'Meara, T. Clayton, M.B. McEntegart, J.J.V. McMurray, C.C. Lang, and S.D. Roger Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program Circulation 113 7 2006 986 994
36. D.S. Silverberg, D. Wexler, M. Blum, G. Keren, D. Sheps, and E. Leibovitch The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalization J. Am. Coll. Cardiol. 35 7 2000 1737 1744
37. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, and K. Dickstein ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur. Heart J. 33 14 2012 1787 1847
38. E.A. Jankowska, P. Rozentryt, A. Witkowska, J. Nowak, O. Hartmann, and B. Ponikowska Iron deficiency: an ominous sign in patients with systolic chronic heart failure Eur. Heart J. 31 15 2010 1872 1880
39. Bobbio-Pallavicini, G. Verde, P. Spriano, R. Losi, M.G. Bosatra, and A. Braschi Body iron status in critically patients: significance of serum ferritin Intensive Care Med. 15 3 1989 171 178
40. R. Ferrari, L. Agnoletti, L. Comini, G. Gaia, T. Bachetti, and A. Cargnoni Oxidative stress during myocardial ischaemia and heart failure Eur. Heart J. 19 Suppl. B 1998 B2 B11
41. C. Opasich, M. Cazzola, L. Scelsi, S. De Feo, E. Bosimini, and R. Lagioia Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anemia in patients with chronic heart failure Eur. Heart J. 26 21 2005 2232 2237
42. P.O. Iversen, P.R. Woldbaek, T. Tonnesen, and G. Christensen Decrease hematopoiesis in bone narrow of mice with congestive heart failure Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 1 2002 R166 R172
43. A.S. Androne, S.D. Katz, L. Lund, J. LaManca, A. Hudaihed, and K. Hryniewicz Hemodilution is common in patients with advanced heart failure Circulation 107 2 2003 226 229
44. B. Herrlin, O. Nyquist, and C. Sylven Induction of a reduction in hemoglobin concentration by enalapril in stable, moderate heart failure: a double-blind study Br. Heart J. 66 33 1991 199 205
45. B. Chatterjee, U.E. Nydegger, and P. Mohacsi Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT (1) antagonists Eur. J. Heart Fail. 2 4 2000 393 398
46. Y.D. Tang, and S.D. Katz Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options Circulation 113 20 2006 2454 2461
47. E. O'Meara, C. Murphy, and J.J. McMurray Anemia and heart failure Curr. Heart Fail. Rep. 1 4 2004 176 182
48. M.W. Klutstein, and D. Tzivoni Anaemia and heart failure: aetiology and treatment Nephrol. Dial. Transplant. 20 Suppl. 7 2005 vii7 vii10
49. D. Mozaffarian, R. Nye, and W.C. Levy Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE) J. Am. Coll. Cardiol. 41 11 2003 1933 1939
50. S.D. Anker, A.J.S. Coats, E.B. Roecker, and The COPERNICUS Study Group Hemoglobin level is associated with mortality and hospitalization in patients with severe chronic heart failure: results from the COPERNICUS study (abstr) J. Am. Coll. Cardiol. 43 Suppl. A 2004 216A
51. A.J. Lipton, M.A. Johnson, T. Macdonald, M.W. Lieberman, D. Gozal, and B. Gaston S-nitrosothiols signal the ventilatory response to hypoxia Nature 413 6852 2001 171 174
52. P. Van der Meer, H.F. Groenveld, J.L. Januzzi, and D.J. van Veldhuisen Erythropoietin treatment in patients with chronic heart failure: a meta-analysis Heart 95 16 2009 1309 1314
53. J.N. Nanas, H. Matsoukas, D. Karageorgopoulos, A. Leonti, E. Tsolakis, and S. Drakos Etiology of anemia in patients with advanced heart failure J. Am. Coll. Cardiol. 48 12 2006 2485 2489
54. G. Filippatos, D. Farmakis, J.C. Colet, K. Dickstein, T.F. Lüscher, and Willenheimer Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial Eur. J. Heart Fail. 15 11 2013 1267 1276
55. P. Ponikowski, D.J. van Veldhuisen, J. Comin-Colet, G. Ertl, M. Komajda, V. Mareev, and for the CONFIRM-HF Investigators Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency Eur. Heart J. 36 11 2015 657 668
56. L. Beck-da-Silva, D. Piardi, S. Soder, L.E. Rohde, A.C. Pereira-Barretto, and D. de Albuquerque IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia Int. J. Cardiol. 168 4 2013 3439 3442
57. A. Palazzuoli, D.S. Silverberg, F. Iovine, A. Calabrò, M.S. Campagna, and M. Gallotta Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome Am. Heart J. 154 4 2007 645.e9 645.e15
58. J. Glaspy, and I. Cavill Role of iron in optimizing responses of anemic cancer patients to erythropoietin Oncology 13 4 1999 461 473
59. I.C. MacDougall Strategies for iron supplementation: oral versus intravenous Kidney Int. Suppl. 69 1999 S61 S66
60. S.R. Pasricha, S.C. Flecknoe-Brown, K.J. Allen, P.R. Gibson, L.P. McMahon, and J.K. Olynyk Diagnosis and management of iron deficiency anaemia: a clinical update Med. J. Aust. 193 9 2010 525 532
61. J.L. Sullivan Long-term risks of increased use of intravenous iron Lancet 370 9586 2007 481 482
62. K.L. Kuo, S.C. Hung, Y.H. Wei, and D.C. Tarng Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients J. Am. Soc. Nephrol. 19 9 2008 1817 1826
63. I. Hussain, J. Bhoyroo, A. Butcher, T.A. Koch, A. He, and D.B. Bregman Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia Anemia 2013 2013 169107 10.1155/2013/169107 (Epub 2013 Aug 29)
64. E.M. Van Craenenbroeck, V.M. Conraads, N. Greenlaw, G. Gaudesius, C. Mori, and P. Ponikowski The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study Eur. J. Heart Fail. 15 7 2013 756 762
65. D.P. Kao, E. Kresno, G.C. Fonarow, and M.J. Krantz Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000-2006) Am. J. Cardiol. 107 1 2011 69 73
66. K. Kourea, J.T. Parissis, D. Farmakis, F. Panou, I. Paraskevaidis, and K. Venetsanou Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure Atherosclerosis 199 1 2008 215 221
67. J.T. Parissis, K. Kourea, F. Panou, D. Farmakis, I. Paraskevaidis, and I. Ikonomidis Effects of darbepoetin α on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am. Heart J. 155 4 2008 751.e1 751.e7
68. G.L. Wright, P. Hanlon, K. Amin, C. Steenbergen, E. Murphy, and M.O. Arcasoy Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury FASEB J. 18 9 2004 1031 1033
69. J.K. Ghali, I.S. Anand, W.T. Abraham, G.C. Fonarow, B. Greenberg, and H. Krum Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia (STAMINA-HeFT study) Circulation 117 4 2008 526 535
70. I.C. Macdougall, Steering Committee of the CREATE trial, and CREATE Study Group CREATE: new strategies for early anaemia management in renal insufficiency Nephrol. Dial. Transplant. 18 Suppl. 2 2003 ii13 ii16
71. J.K. Inrig, H.X. Barnhart, D. Reddan, U.D. Patel, S. Sapp, and R.M. Califf Effect of Haemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial Am. J. Kidney Dis. 60 3 2012 390 401
72. M.A. Pfeffer, E.A. Burdmann, C.Y. Chen, M.E. Cooper, D. de Zeeuw, K.U. Eckardt, and TREAT Investigators A trial of darbepoetin alfa in type II diabetes and chronic kidney disease N. Engl. J. Med. 361 21 2009 2019 2032
73. K. Swedberg, J.B. Young, I.S. Anand, S. Cheng, A.S. Desai, R. Diaz, RED-HF Committees, and RED-HF Investigators Treatment of anemia with darbepoetin alfa in systolic heart failure N. Engl. J. Med. 368 13 2013 1210 1219
74. B. Leyland-Jones Breast cancer trial with erythropoietin terminated unexpectedly Lancet Oncol. 4 8 2003 459 460
75. National Kidney Foundation Kidney Disease Outcomes Quality Initiative Available at http://www.kidney.org/professionals/KDOQI/ (Assessed June 9, 2008)
76. M.J. Sarnak, H. Tighiouart, G. Manjunath, B. MacLeod, J. Griffith, and D. Salem Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study J. Am. Coll. Cardiol. 40 1 2002 27 33
77. D. Brawn, W. Giles, and J. Croft Hematocrit and risk of coronary heart disease Am. Heart J. 142 4 2001 657 663